Video

VIDEO – ‘Clear’ link between cannabis use and schizophrenia


 

AT THE INTERNATIONAL CONGRESS ON SCHIZOPHRENIA RESEARCH

References

COLORADO SPRINGS – Not all people who use cannabis will become psychotic, but for those with just the right constellation of risk factors, cannabis can lead to “chronic schizophrenia,” according to Sir Robin M. Murray, professor of psychiatric research at the Institute of Psychiatry at King’s College London.

And although Dr. Murray says “old-fashioned” cannabis can lead to psychosis, it’s the newer, more potent kinds manufactured in the last decade that pose the greatest risk.

In this interview, recorded at the International Congress on Schizophrenia Research, Dr. Murray discusses the evidence establishing the links between psychosis, schizophrenia, and cannabis, and what clinicians can do to help patients who might be at risk. He warns, however, that not everyone will be able to reverse the damage to the brain that cannabis can cause.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

Schizophrenia, but not bipolar disorder, linked to social cognition deficits
MDedge Psychiatry
Abnormal calcium level in a psychiatric presentation? Rule out parathyroid disease
MDedge Psychiatry
Oversight of antipsychotic use in Medicaid-insured children varies by state
MDedge Psychiatry
Dimensional aspects of DSM-5 personality disorder criteria discussed
MDedge Psychiatry
Schizophrenia patients twice as likely to be at risk for DVT and PE
MDedge Psychiatry
Impaired self-assessment in schizophrenia: Why patients misjudge their cognition and functioning
MDedge Psychiatry
FDA calls study of unexplained olanzapine deaths ‘inconclusive’
MDedge Psychiatry
Three-month injectable paliperidone palmitate delayed relapse in schizophrenia up to 1 year
MDedge Psychiatry
Benzodiazepine reduction without withdrawal symptoms possible in patients with schizophrenia, bipolar disorder
MDedge Psychiatry
Aripiprazole outperforms paliperidone palmitate in head-to-head trial
MDedge Psychiatry